|
Pharmacology
Citations 111-120 of 165 total displayed.
|
Past content
(since Dec 2002):
|
- CLINICAL
Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation
- E. K. Li, J. F. Griffith, V. W. Lee, Y.-X. Wang, T. K. Li, K. K. Lee, and L.-S. Tam
Rheumatology 2008; 47: 1358-1363.
[Abstract]
[Full Text]
- CLINICAL
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study
- G. Karanikolas, D. Charalambopoulos, G. Vaiopoulos, A. Andrianakos, A. Rapti, D. Karras, E. Kaskani, and P. P. Sfikakis
Rheumatology 2008; 47: 1384-1388.
[Abstract]
[Full Text]
- CLINICAL
The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice
- N. Smith, T. Ding, S. Butt, K. Gadsby, and C. Deighton
Rheumatology 2008; 47: 1389-1391.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study
- A. Kaul, D. T. O’Reilly, R. K. Slack, D. Collins, J. Walmsley, O. Duke, and P. D. W. Kiely
Rheumatology 2008; 47: 1430-1431.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy
- C. Thornton, V. Ong, J. Ward, N. Kennedy, and A. Steuer
Rheumatology 2008; 47: 1438.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy: reply
- A. Bharadwaj, M. Batley, and A. H. Hammond
Rheumatology 2008; 47: 1438-a.
[Extract]
[Full Text]
- REVIEWS
Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies
- S. Perrot, R.-M. Javier, M. Marty, C. Le Jeunne, F. Laroche, and the CEDR (Cercle d’Etude de la Douleur en Rhumatologie France), French Rheumatological Society, Pain Study Section
Rheumatology 2008; 47: 1117-1123.
[Abstract]
[Full Text]
- BASIC SCIENCE
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
- S. L. Hider, W. Thomson, L. F. Mack, D. J. Armstrong, M. Shadforth, and I. N. Bruce
Rheumatology 2008; 47: 1156-1159.
[Abstract]
[Full Text]
[ Supplementary Data ]
- CASE REPORTS
Acute psychosis in three patients receiving anti-tumour necrosis factor- therapy
- L. McGregor, S. A. Saunders, J. A. Hunter, and E. Murphy
Rheumatology 2008; 47: 1254-1255.
[Extract]
[Full Text]
- CLINICAL
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
- K. L. Hyrich, M. Lunt, W. G. Dixon, K. D. Watson, D. P. M. Symmons, and on behalf of the BSR Biologics Register
Rheumatology 2008; 47: 1000-1005.
[Abstract]
[Full Text]
|
|
